Cohance Lifesciences Limited
NSE: COHANCE | Information Technology
Market Fundamentals
Stock Intelligence & News
Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Cohance Lifesciences Limited
Berhyanda Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Cohance Q4 Profit Slumps 72%, ICICI Securities Downgrades to Reduce'
While Cohance continues to have a strong near-term pipeline of four late-stage phase3 projects, commercialisation timelines for these remain uncertain.
Read Full Analysis →Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4
Cohance Lifesciences shares dropped significantly after reporting an 84% year-on-year decline in March-quarter net profit. Jefferies downgraded the stock to "Underperform" citing management instability and weak visibility, while Goldman Sachs maintained its "Buy" rating, seeing long-term opportunities despite a challenging near-term outlook.
Read Full Analysis →Jefferies Downgrades A Stock That Has Gained 33% In Three Weeks
The brokerage cuts Cohance Life to Underperform, citing weak fundamentals that it says the recent rally hasn't priced in.
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Get instant alerts when COHANCE breaks news
Join investors who track Cohance Lifesciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for COHANCE?
COHANCE is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Cohance Lifesciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding COHANCE to your custom watchlist.